¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dominant exudative vitreoretinopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´(Áõ)
  • vitreoretinopathy
    À¯¸®Ã¼¸Á¸·º´(Áõ)
  • exudative
    ȕ̉-
  • exudative arthritis
    »ïÃâ°üÀý¿°
  • exudative choroiditis
    »ïÃâ¸Æ¶ô¸·¿°
  • exudative cystitis
    »ïÃâ¹æ±¤¿°
  • exudative drusen
    »ïÃâµå·çÁ¨, »ïÃâ°áÁ¤Ã¼
  • exudative inflammation
    »ïÃâ¿°Áõ
  • exudative laryngitis
    »ïÃâÈĵο°
  • exudative otitis media
    »ïÃâÁßÀÌ¿°
  • exudative peritonitis
    »ïÃ⺹¸·¿°, »ïÃâ¹è¸·¿°
  • exudative proliferative glomerulonephritis
    »ïÃâÁõ½ÄÅ丮ÄáÆÏ¿°, »ïÃâÁõ½Ä»ç±¸Ã¼½Å¿°
  • exudative retinitis
    »ïÃâ¸Á¸·¿°
  • exudative retinopathy
    »ïÃâ¸Á¸·º´(Áõ)
  • autosomal dominant disorder
    º¸Åë¿°»öü¿ì¼ºÁúȯ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vitreoretinopathy
    À¯¸®Ã¼¸Á¸·º´Áõ
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • dominant eye
    ¿ì¼¼¾È
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • vitreoretinopathy
    À¯¸®Ã¼¸Á¸·º´Áõ
  • autosomal dominant disorder
    º¸Åë¿°»öü¿ì¼ºÁúȯ
  • autosomal dominant trait
    º¸Åë¿°»öü¿ì¼º¼ÒÁú
  • exudative arthritis
    »ïÃâ°üÀý¿°
  • dominant character
    ¿ì¼ºÇüÁú, Áö¹èÀûÇüÁú
  • dominant complement
    ¿ì¼ºµµ¿òü
  • exudative choroiditis
    »ïÃâ¸Æ¶ô¸·¿°
  • exudative cystitis
    »ïÃâ¹æ±¤¿°
  • dominant
    ¿ì¼º-, ¿ì¼¼-, ¿ìÀ§-, ¿ì¼º
  • dominant eye
    ¿ì¼¼¾È
  • dominant gene
    ¿ì¼ºÀ¯ÀüÀÚ
  • dominant hemisphere
    ¿ì¼º´ë³ú¹Ý±¸
  • dominant inheritance
    ¿ì¼ºÀ¯Àü
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • PVR=>proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • hemorrhagic exudative erythema
    ÃâÇ÷(¼º) »ïÃ⼺ È«¹Ý
  • pharyngitis, exudative
    »ïÃ⼺ Àεο°
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dominant exudative vitreoretinopathy
    ¿ì¼º»ïÃâÀ¯¸®Ã¼¸Á¸·º¯Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial exudative vitreoretinopathy
    °¡Á·¼º»ïÃâÀ¯¸®Ã¼¸Á¸·º´Áõ
  • proliferative vitreoretinopathy
    Áõ½ÄÀ¯¸®Ã¼¸Á¸·º´Áõ
  • vitreoretinopathy
    À¯¸®Ã¼¸Á¸·º´Áõ
  • external exudative retinopathy
    ¿Ü»ïÃâ¸Á¸·º´Áõ
  • exudative
    »ïÃ⼺(ß¶õóàõ)ÀÇ.
  • exudative albuminuria
    »ïÃ⼺ ´Ü¹é´¢.
  • exudative arthritis
    »ïÃ⼺ °üÀý¿°.
  • exudative bronchiolitis
    »ïÃ⼺ ¼¼±â°üÁö¿°.
  • exudative choroiditis
    »ïÃâ¸Æ¶ô¸·¿°.
  • exudative chronic discoid and lichenoid dermatitis
    »ïÃ⼺ ¸¸¼º ¿øÆÇ»ó ż±¾ç ÇǺο°
  • exudative cystitis
    »ïÃ⼺ ¹æ±¤¿°.
  • exudative diathesis
    »ïÃ⼺ ¼ÒÁú.
  • exudative inflammation
    »ïÃ⼺ ¿°Áõ(ß¶õóàõæúñø)
  • exudative laryngitis
    »ïÃâ(¼º) Èĵο°
  • exudative nephritis
    »ïÃ⼺ ½ÅÀå¿°.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Dominant autosomal gene
    ¿ì¼ºº¸Åë¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] ¿ì¼º»ó¿°»öüÀ¯ÀüÀÚ
  • Dominant gonosomal gene
    ¿ì¼º¼º¿°»öüÀ¯ÀüÀÚ
    [¿¾ ¿ë¾î] ¿ì¼º¼º¿°»öüÀ¯ÀüÀÚ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cis-dominant
    ½Ã½º ¿ì¼º(éÐàõ)
  • dominant
    ¿ì¼º(éÐàõ)
  • dominant gene
    ¿ì¼º À¯ÀüÀÚ(éÐàõë¶îîí­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exudative
    »ïÃ⼺ÀÇ
  • exudative peritonitis
    »ïÃ⼺º¹¸·¿°
  • autosomal dominant inheritance
    »ó¿°»öü¿ì¼ºÀ¯ÀüÁúȯ
  • dominant
    ¿ì¼ºÀÇ
  • dominant hemisphere
    Áö¹è´ë³ú¹Ý±¸
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EVR evoked visual response; exudative vitreoretinopathy
EVXX exudative vitreoretinopathy, X-linked
FEV familial exudative vitreoretinopathy; forced expiratory volume
FEVR familial exudative vitreoretinopathy
VRNI neovascular inflammatory vitreoretinopathy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FEVR Familial Exudative Vitreoretinopathy
PSE Pale, soft, exudative
PVR Proliferative Vitreoretinopathy
AD Autosomal Dominant
ADCA Autosomal Dominant Cerebellar Ataxia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dominant exudative vitreoretinopathy
    ¿ì¼º »ïÃâÀ¯¸®Ã¼ ¸Á¸·º¯Áõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • edematous-exudative epithelial cloudiness
    ºÎÁ¾ »ïÃ⼺ »óÇÇ È¥Å¹
  • exudative inflammation
    »ïÃ⼺ ¿°Áõ
  • exudative peritonitis
    »ïÃ⼺ º¹¸·¿°
  • exudative tuberculosis
    »ïÃ⼺ °áÇÙ
  • heavy exudative
    ½ÉÇÑ »ïÃâ
  • autosomal dominant disorder
    »ó¿°»öü ¿ì¼º À¯Àü Áúȯ
  • autosomal dominant trait
    »ó¿°»öü ¿ì¼º À¯Àü ÇüÁú
  • dominant
    ¿ì¼º, ¿ì¼ºÀÇ
    1. ¿ì¼¼ ¶Ç´Â Áö¹èÀû ¿µÇâÀ» ¹ßÈÖÇÏ´Â. À¯ÀüÇп¡¼­´Â ÇÑ ½ÖÀÌ »óµ¿¿°»öü ÇÑ Âʸ¸À¸·Î ¿î¹ÝµÇ¾îµµ ¹ßÇö °¡´ÉÇÑ. 2. ¿ì¼º ÇüÁú. ¿ì¼º ¼ÒÁú.
  • dominant character
    ¿ì¼º ÇüÁú, Áö¹èÀû Ư¼º
  • dominant cystoid macular dystrophy
    ¿ì¼º ³¶Æ÷ Ȳ¹Ý ÀÌ¿µ¾çÁõ
  • dominant gene
    ¿ì¼º À¯ÀüÀÚ
  • dominant inheritance
    ¿ì¼º À¯Àü
  • dominant receptor
    ¿ì¼º ¼ö¿ëü
  • dominant trait
    ¿ì¼º ¼ÒÁú
  • pedigree pattern of autosomal dominant trait
    »ó¿°»öü¼º ¿ì¼º ÇüÁúÀÇ °¡°èµµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
exudative vitreoretinopathy <ophthalmology> A familial, slowly progressive ocular disease; characterised by posterior vitreous detachment, vitreous membranes, heterotopia of macula, retinal detachment, neovascularization, and recurrent haemorrhage.
(06 Mar 2000)
vitreoretinopathy Retinopathy with vitreous complications.
(05 Mar 2000)
vitreoretinopathy, proliferative Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
(12 Dec 1998)
haemorrhagic exudative erythema <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
epidermitis, exudative, of swine An acute generalised dermatitis of pigs which occurs from 5 to 35 days of age, characterised by sudden onset, with morbidity of 10 to 90% and mortality of 5 to 90%. The lesions are caused by staphylococcus hyos but the bacterial agent is unable to penetrate the intact skin. Abrasions on the feet and legs or lacerations on the body frequently precede infection. In acute cases, a vesicular-type virus may be the predisposing factor. The causative organism is inhibited by most antibiotics. (merck veterinary manual, 5th ed)
(12 Dec 1998)
external exudative retinopathy See: exudative retinitis.
(05 Mar 2000)
exudative Relating to the process of exudation or to an exudate.
(05 Mar 2000)
exudative angina <infectious disease, paediatrics> This has nothing whatsoever to do with the commonly known angina (angina pectoris) in adults with chest pain of cardiac origin.
Exudative angina is more commonly known as croup, an infection of the larynx, trachea, and the bronchial tubes, largely in children.
Caused usually by viruses, less often by bacteria. Symptoms include a cough that sounds like a barking seal and a harsh crowing sound during inhaling.
Treatment can include moist air, salt water nose drops, decongestants and cough suppressants, pain medication, fluids, and occasionally antibiotics. The major concern in croup is breathing difficulty as the air passages narrow. Close monitoring of the breathing of a child with croup is important, especially at night.
While most children recover from croup without hospitalization, some children can develop life-threatening breathing difficulties. Therefore, close contact with the doctor during this illness is important.
(06 Mar 2000)
exudative bronchiolitis Inflammation of the bronchioles, with fibrinous exudation.
(05 Mar 2000)
exudative choroiditis A circumscribed inflammation of the choroid, often with multiple lesions.
(05 Mar 2000)
exudative discoid and lichenoid dermatitis Disease resembling an exudative form of nummular eczema described in Jewish males with oval lesions on the penis, trunk, and face.
Synonym: exudative discoid and lichenoid dermatitis, Sulzberger-Garbe syndrome.
(05 Mar 2000)
exudative glomerulonephritis Glomerulonephritis with infiltration of glomeruli by polymorphonuclear leukocytes, occurring in acute glomerulonephritis.
(05 Mar 2000)
exudative inflammation Inflammation in which the conspicuous or distinguishing feature is an exudate, which may be chiefly serous, serofibrinous, fibrinous, or mucous (e.g., relatively few cells are present), or may be characterised by relatively large numbers of neutrophils, eosinophils, lymphocytes, monocytes, or plasma cells, frequently with one or two types being predominant; it occurs not only as a separate and distinct pathologic process, but also frequently as a part of certain granulomatous inflammation's.
(05 Mar 2000)
exudative retinal detachment Detachment of the retina without retinal breaks, arising from inflammatory disease of choroid, retinal tumours, and retinal angiomatosis.
(05 Mar 2000)
exudative retinitis Retinitis exudativa, a chronic abnormality characterised by deposition of cholesterol and cholesterol esters in outer retinal layers and subretinal space. In adults, often preceded by uveitis; in children, often preceded by retinal vascular abnormalities.
Synonym: Coats' disease.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dominant
    ¿ì¼¼ÇÑ;Áö¹èÀûÀÎ;¿ì¼ºÀÇ;µþ¸²À½ÀÇ;¼ÓÀ½ÀÇ
  • dominant character
    (»ý)¿ì¼º ÇüÁú
  • dominant gene
    (»ý)¿ì¼º À¯ÀüÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á